WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
maximize
Machine translation
1. (WO2010065400) CANCER BIOMARKER AND METHODS OF USING THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/065400    International Application No.:    PCT/US2009/065742
Publication Date: 10.06.2010 International Filing Date: 24.11.2009
IPC:
G01N 33/574 (2006.01), A61K 39/00 (2006.01)
Applicants: UNIVERSITY OF UTAH RESEARCH FOUNDATION [US/US]; 615 Arapeen Drive, Suite 310 Salt Lake City, UT 84108 (US) (For All Designated States Except US).
TANTIN, Dean [US/US]; (US) (For US Only).
SHAKYA, Arvind [IN/US]; (IN) (For US Only)
Inventors: TANTIN, Dean; (US).
SHAKYA, Arvind; (IN)
Agent: BRIAN, Giles, P.; (US)
Priority Data:
61/200,719 03.12.2008 US
61/245,008 23.09.2009 US
Title (EN) CANCER BIOMARKER AND METHODS OF USING THEREOF
(FR) BIOMARQUEUR DU CANCER ET PROCÉDÉS D’UTILISATION DE CELUI-CI
Abstract: front page image
(EN)Described herein are biomarkers which can be used for identifying a subject at risk for or evaluating the progression of cancer. In certain aspects, these biomarkers can be used to identify cancer stem cells. These biomarkers can include, but are not limited to, Oc1 or molecular variants thereof, Oc1 target proteins, or a combination thereof. In addition, described herein are methods for reducing the expression of these biomarkers associated with cancer.
(FR)La présente invention concerne des biomarqueurs qui peuvent être utilisés pour identifier un sujet à risque de ou évaluer la progression d’un cancer. Dans certains aspects, ces biomarqueurs peuvent être utilisés pour identifier des cellules souches cancéreuses. Ces biomarqueurs peuvent comprendre, mais ne sont pas limités à, Oc1 ou des variants moléculaires de celui-ci, des protéines cibles Oc1, ou une combinaison de ceux-ci. De plus, la présente invention concerne des procédés pour réduire l’expression de ces biomarqueurs associés au cancer.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)